These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 19167641

  • 1. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.
    Ogata H, Ishikawa Y, Ishikawa Y, Minami R.
    J Cardiol; 2009 Feb; 53(1):72-8. PubMed ID: 19167641
    [Abstract] [Full Text] [Related]

  • 2. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
    Viollet L, Thrush PT, Flanigan KM, Mendell JR, Allen HD.
    Am J Cardiol; 2012 Jul 01; 110(1):98-102. PubMed ID: 22463839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
    Fayssoil A.
    Indian Heart J; 2010 Jul 01; 62(3):273. PubMed ID: 21275309
    [Abstract] [Full Text] [Related]

  • 5. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up.
    Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Bécane HM.
    Am Heart J; 2007 Sep 01; 154(3):596-602. PubMed ID: 17719312
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy.
    Judge DP, Kass DA, Thompson WR, Wagner KR.
    Am J Cardiovasc Drugs; 2011 Oct 01; 11(5):287-94. PubMed ID: 21812510
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R, Wang Y, Foody JM.
    Am J Cardiol; 2008 Jan 15; 101(2):217-22. PubMed ID: 18178410
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM, Holubkov R, Postava L, Janosko K, MacGowan GA, Mathier M, Murali S, Feldman AM, London B.
    J Am Coll Cardiol; 2004 Nov 16; 44(10):2019-26. PubMed ID: 15542286
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 16; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 12. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA.
    Circulation; 2005 Nov 01; 112(18):2799-804. PubMed ID: 16246949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Management of myocardial damage in muscular dystrophy].
    Tamura T.
    Brain Nerve; 2011 Nov 01; 63(11):1217-28. PubMed ID: 22068474
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT, Yusuf S, Rouleau JL, Maggioni AP, McKelvie RS, Wiecek EM, Wang Y, Pogue J, Teo KK, White M, Avezum A, Latini R, Held P, Lindgren E, Probstfield J.
    Can J Cardiol; 1997 Dec 01; 13(12):1166-74. PubMed ID: 9444298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP.
    Dev Med Child Neurol; 2006 Mar 01; 48(3):164. PubMed ID: 16483389
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.